IP Library Granted Patent US 7,244,759
Granted Patent B2
US 7,244,759 · App. 10/900,270 · Granted Jul 17, 2007

Isoindoline compounds and methods of making and using the same

Assignee: Celgene Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,244,759
App. No.
10/900,270
Granted
Jul 17, 2007
Kind
B2
Abstract

The invention encompasses isoindoline compounds, pharmaceutical compositions comprising them, and methods of their use for the treatment, prevention or management of various diseases and disorders. Examples include, but are not limited to, cancer, inflammatory bowel disease and myelodysplastic syndrome.

Claims (6)

1. A pharmaceutical composition comprising a compound, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, wherein the compound is:

2. The pharmaceutical composition of claim 1 , which further comprises a pharmaceutically acceptable carrier or excipient.

3. A dosage form comprising a compound, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, wherein the compound is:

4. The dosage form of claim 3 , which is suitable for oral or parenteral administration.

5. The pharmaceutical composition of claim 1 , wherein the solvate is hydrate.

6. The dosage form of claim 3 , wherein the solvate is hydrate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2019
From: CELGENE CORPORATION
To: AMGEN INC.
Reel/Frame 051181/0038 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2004
From: MULLER, GOERGE W.; MAN, HON-WAH
To: CELGENE CORPORATION
Reel/Frame 016018/0203 →
Continuity (1)
Related Publication 20060084815A1 · Apr 20, 2006